Insight Molecular Diagnostics Inc. Stock-Based Compensation
Insight Molecular Diagnostics Inc. (IMDX) reported Stock-Based Compensation of $1.28 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-10
- Insight Molecular Diagnostics Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $661.00K, a 31.15% increase year-over-year.
- Insight Molecular Diagnostics Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $615.00K, a 30.02% increase year-over-year.
- Insight Molecular Diagnostics Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $721.00K, a 44.49% increase year-over-year.
- Insight Molecular Diagnostics Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $521.00K, a 15.78% increase year-over-year.
- Insight Molecular Diagnostics Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $2.22M, a 26.58% increase from fiscal 2024.
- Insight Molecular Diagnostics Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $1.75M, a 36.49% decline from fiscal 2023.
- Insight Molecular Diagnostics Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $2.76M, a 72.52% decline from fiscal 2022.
- Insight Molecular Diagnostics Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $10.04M, a 46.79% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $661.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $1.28M 10-Q · filed 2026-08-10 | $2.00M derived: sum of 3 quarters · filed 2026-08-10 | $2.52M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $615.00K 10-Q · filed 2026-05-13 | $1.34M derived: sum of 2 quarters · filed 2026-05-13 | $1.86M derived: sum of 3 quarters · filed 2026-05-13 | $2.36M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $721.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $1.24M derived: sum of 2 quarters · filed 2026-03-26 | $1.75M derived: sum of 3 quarters · filed 2026-08-10 | $2.22M 10-K · filed 2026-03-26 |
| 2025-09-30 | $521.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.02M derived: sum of 2 quarters · filed 2026-08-10 | $1.50M 10-Q · filed 2025-11-10 | $2.00M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $504.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $977.00K 10-Q · filed 2026-08-10 | $1.48M derived: sum of 3 quarters · filed 2026-08-10 | $1.93M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $473.00K 10-Q · filed 2026-05-13 | $972.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.42M derived: sum of 3 quarters · filed 2026-05-13 | $1.81M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $499.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $949.00K derived: sum of 2 quarters · filed 2026-03-26 | $1.33M derived: sum of 3 quarters · filed 2026-03-26 | $1.75M 10-K · filed 2026-03-26 |
| 2024-09-30 | $450.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $836.00K derived: sum of 2 quarters · filed 2025-11-10 | $1.25M 10-Q · filed 2025-11-10 | $1.74M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $386.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $804.00K 10-Q · filed 2025-08-11 | $1.29M derived: sum of 3 quarters · filed 2025-08-11 | $1.90M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $418.00K 10-Q · filed 2025-05-12 | $902.00K derived: sum of 2 quarters · filed 2025-05-12 | $1.51M derived: sum of 3 quarters · filed 2025-05-12 | $2.34M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $484.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $1.09M derived: sum of 2 quarters · filed 2025-03-24 | $1.93M derived: sum of 3 quarters · filed 2025-03-24 | $2.76M 10-K · filed 2025-03-24 |
| 2023-09-30 | $608.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.44M derived: sum of 2 quarters · filed 2024-11-12 | $2.28M 10-Q · filed 2024-11-12 | $4.89M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $834.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.67M 10-Q · filed 2024-08-08 | $4.29M derived: sum of 3 quarters · filed 2024-08-08 | $7.47M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $834.00K 10-Q · filed 2024-05-15 | $3.45M derived: sum of 2 quarters · filed 2024-05-15 | $6.63M derived: sum of 3 quarters · filed 2024-05-15 | $8.87M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $5.80M derived: sum of 2 quarters · filed 2024-04-16 | $8.03M derived: sum of 3 quarters · filed 2024-04-16 | $10.04M 10-K · filed 2024-04-16 |
| 2022-09-30 | $3.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $5.41M derived: sum of 2 quarters · filed 2023-11-09 | $7.42M 10-Q · filed 2023-11-09 | $9.13M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $2.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $4.24M 10-Q · filed 2023-08-10 | $5.95M derived: sum of 3 quarters · filed 2023-08-10 | $7.80M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $2.01M 10-Q · filed 2023-05-15 | $3.71M derived: sum of 2 quarters · filed 2023-05-15 | $5.57M derived: sum of 3 quarters · filed 2023-05-15 | $7.56M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-12 | $3.56M derived: sum of 2 quarters · filed 2023-04-12 | $5.55M derived: sum of 3 quarters · filed 2023-04-12 | $6.84M 10-K · filed 2023-04-12 |
| 2021-09-30 | $1.85M 10-Q · filed 2021-11-09 | $3.85M derived: sum of 2 quarters · filed 2021-11-09 | $5.14M 10-Q · filed 2022-11-10 | $6.12M derived: sum of 4 quarters · filed 2022-05-12 |
| 2021-06-30 | $2.00M 10-Q · filed 2021-08-11 | $3.29M 10-Q · filed 2022-08-12 | $4.27M derived: sum of 3 quarters · filed 2022-05-12 | $6.05M derived: sum of 4 quarters · filed 2022-05-12 |
| 2021-03-31 | $1.29M 10-Q · filed 2022-05-12 | $2.27M derived: sum of 2 quarters · filed 2022-05-12 | $4.06M derived: sum of 3 quarters · filed 2022-05-12 | $5.42M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $985.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $2.77M derived: sum of 2 quarters · filed 2022-03-11 | $4.13M derived: sum of 3 quarters · filed 2022-03-11 | $5.07M 10-K · filed 2022-03-11 |
| 2020-09-30 | $1.78M 10-Q · filed 2021-11-09 | $3.15M derived: sum of 2 quarters · filed 2021-11-09 | $4.08M 10-Q · filed 2021-11-09 | $4.87M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $1.36M 10-Q · filed 2021-08-11 | $2.30M 10-Q · filed 2021-08-11 | $3.08M derived: sum of 3 quarters · filed 2021-08-11 | $3.90M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $937.00K 10-Q · filed 2021-05-17 | $1.72M derived: sum of 2 quarters · filed 2021-05-17 | $2.54M derived: sum of 3 quarters · filed 2021-05-17 | $3.25M derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $786.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | $1.61M derived: sum of 2 quarters · filed 2021-03-19 | $2.31M derived: sum of 3 quarters · filed 2021-03-19 | $3.00M 10-K · filed 2021-03-19 |
| 2019-09-30 | $821.00K 10-Q · filed 2020-11-12 | $1.52M derived: sum of 2 quarters · filed 2020-11-12 | $2.21M 10-Q · filed 2020-11-12 | $2.61M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $701.00K 10-Q · filed 2020-07-29 | $1.39M 10-Q · filed 2020-07-29 | $1.79M derived: sum of 3 quarters · filed 2020-07-29 | $2.13M derived: sum of 4 quarters · filed 2020-07-29 |
| 2019-03-31 | $686.00K 10-Q · filed 2020-05-12 | $1.09M derived: sum of 2 quarters · filed 2020-05-12 | $1.43M derived: sum of 3 quarters · filed 2020-05-12 | $1.82M derived: sum of 4 quarters · filed 2020-05-12 |
| 2018-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $744.00K derived: sum of 2 quarters · filed 2020-03-26 | $1.13M derived: sum of 3 quarters · filed 2020-03-26 | $1.48M 10-K · filed 2020-03-26 |
| 2018-09-30 | $344.00K 10-Q · filed 2019-11-14 | $733.00K derived: sum of 2 quarters · filed 2019-11-14 | $1.08M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $389.00K 10-Q · filed 2019-08-14 | $735.00K 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $347.00K 10-Q · filed 2019-05-14 | |||
| 2017-12-31 | $1.63M 10-K · filed 2019-04-01 | |||
| 2016-03-31 | $125.00K 10-Q · filed 2016-05-16 | |||
| 2015-03-31 | $216.00K 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |